$MSCI

Transcript: MSCI Q2 2026 Earnings Conference Call

MSCI (NYSE:MSCI) reported Q2 2026 results on a conference call. The company said organic revenue growth was over 12%, adjusted EPS growth nearly 19%, and adjusted EBITDA growth 14%. It cited total run rate growth of 12%, ABF run rate growth of 25% to $948 million, and ETF-linked inflows of nearly $40 billion. MSCI repurchased $147 million of shares at about $558 average.

Original reporting
Published Jul 22, 2026, 10:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 2:04 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MSCI
Bullish
medium confidence
Mentioned
$MSCI
Relevance
7/10
alphai data visualization · based on sahmcapital.com
Decision brief

The 30-second read

$MSCIBullishMed
01

Why it matters

The newest actionable information is the set of quantified Q2 performance metrics (organic growth, EPS/EBITDA growth, run-rate growth, ETF inflows, retention) plus the disclosed buyback amount and average repurchase price.

02

Market read

Quantified beat-like growth and strong ETF-linked AUM inflows can drive near-term estimate revisions and sentiment for MSCI’s recurring fee model.

03

What to watch

The transcript emphasizes AI and partnerships, but it does not provide detailed forward guidance ranges; traders may need to wait for the accompanying earnings presentation and any explicit outlook language.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session positioning following the Q2 2026 earnings call transcript

Background

The article is a full transcript of MSCI’s Q2 2026 earnings conference call, following an earlier press release and earnings presentation.

Company-level read

Ticker impact

$MSCIBullishMedium confidence
Context

MSCI reports Q2 2026 organic revenue growth over 12%, adjusted EPS growth nearly 19%, and adjusted EBITDA growth 14% on the call transcript.

Expected impact

Likely positive bias for the next trading session and into follow-on analyst revisions, assuming the market was not already fully positioned for these figures.

Evidence & confidence

The transcript provides multiple quantified performance metrics (growth rates, run-rate, inflows, buyback size) that can drive estimate changes and sentiment, but it is a transcript rather than a fresh guidance update beyond the reported quarter.

Market effects

Reinforces demand strength for index-linked products and private assets analytics, a read-through for the broader market-data and index franchise space.

No specific regional shock cited; commentary spans client segments and geographies.

ETF and index-linked AUM growth is globally relevant and can influence sentiment toward passive/quant infrastructure providers.

Counterpoint

Sustainability challenges are still cited, and Private Assets growth may be more sensitive to capital markets conditions than Index fee run-rate.

Key entities

  • MSCI

    Index, analytics, and private assets data provider reporting Q2 2026 results and run-rate metrics.

  • UBS

    Named as a partnership to enhance wealth management solutions (no deal terms provided in the excerpt).

Related articles

$SNDKMed

Stocks Gain as Chipmakers Rebound

Stocks rose as chipmakers and AI-infrastructure shares rebounded. The iShares Semiconductor ETF (SOXX) gained over 3%, while Sandisk (SNDK), Micron (MU), Western Digital (WDC), and others rose. Bitcoin hit a 1-month high, lifting Coinbase (COIN) and Circle (CRCL). Hasbro (HAS) reported Q2 net revenue $1.14B and raised guidance; 3M (MMM) beat EPS and lifted outlook.

$MSCIMed

MSCI-Linked ETF AUM Tops $2.8 Trillion, but Investors Still Sold the Stock - MSCI (NYSE:MSCI)

MSCI reported operating revenue of $867 million, up 12.2% year over year, slightly above expectations of $866.4 million, driven by higher recurring subscription and asset-based fees. MSCI-linked ETF AUM rose above $2.8 trillion on nearly $40 billion in Q2 inflows. Despite record inflows, MSCI shares fell about 10% Tuesday to $561.74. The company raised 2026 cash flow and expense outlooks.

$MSCIMedAI 8/10

Why MSCI Stock Is Plummeting Lower Today

MSCI shares fell about 10% to around $561.74 after the company reported Q2 results that missed Wall Street expectations, despite sales up 12% and adjusted EPS up 19%. MSCI also slightly raised 2026 expense guidance tied to integrating First Street. Investors are reacting to the earnings and guidance.

$MSCIMed

MSCI Q2 Earnings Call Highlights

MSCI reported Q2 results on its earnings call. CFO Andy Wiechmann said the asset-based fee run rate neared $950 million and ETF AUM linked to MSCI indexes rose to over $2.8 trillion. Management cited 17% index run rate growth, 41% recurring net new sales growth, and retention above 97%, plus Private Assets growth and AI product adoption. Sustainability and climate sales faced cancellations; guidance turned roughly zero to slightly negative.